The Chemours Company
US ˙ NYSE ˙ US1638511089

Introduction

This page provides a comprehensive analysis of the known insider trading history of E Bryan Snell. Insiders are officers, directors, or significant investors in a company. It is illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4. Despite these restrictions, academic research suggests that insiders - in general - tend to outperform the market in their own companies.

Average Trade Profitability

The average trade profitability is the average return of all the open market purchases made by the insider in the last three years. To calculate this, we examine every open-market, unplanned purchase made by the insider, excluding all trades that were marked as part of a 10b5-1 trading plan. We then calculate the average performance of those trades over 3, 6, and 12 months, averaging each of those durations to generate a final performance metric for each trade. Finally, we average all of the performance metrics to calculate a performance metric for the insider. This list only includes insiders that have made at least three trades in the last two years.

If this insiders trade profitability is "N/A", then the insider either has not made any open-market purchases in the last three years, or the trades they’ve made are too recent to calculate a reliable performance metric.

Update Frequency: Daily

See the list of most profitable insider traders.

Companies with Reported Insider Positions

The SEC filings indicate E Bryan Snell has reported holdings or trades in the following companies:

Security Title Latest Reported Holdings
US:CC / The Chemours Company President, Titanium Tech 66,461
How to Interpret the Charts

The following charts show the stock performance of securities subsequent to each open-market, non-planned trade made by E Bryan Snell. Non-planned trade are trades that were not made as part of a 10b5-1 trading plan. The stock performance is charted as cumulative percent change in share price. For example, if an insider trade was made on January 1, 2019, the chart will show the daily percent change of the security to the present day. If the share price were to go from $10 to $15 during this time, the cumulative percent change in share price would be 50%. A change in price from $10 to $20 would be 100%, and a change in price of $10 to $5 would be -50%.

Ultimately, we are trying to determine how closely the insider’s trades correlate to excess returns (positive or negative) in the share price in order to see if the insider is timing their trades to profit from insider information. Consider the situation where an insider was doing this. In this situation, we would expect either (a) positive returns after purchases, or (b) negative returns after sales. In the case of (a), the PURCHASE chart would show a series of upwardly sloping curves, indicating positive returns after each purchase transaction. In the case of (b), the SALE chart would show a series of downward sloping curves, indicating negative returns after each sale transaction.

However, this alone is not enough to draw conclusions. If, for example, the share price of the company was in a non-cyclical climb over many years, then we would expect all the post-purchase plots to be upwardly sloping. Likewise, non-cyclical declines over many years would result in downward sloping post-trade plots. Neither of these charts would suggest insider trading activity.

The strongest indicator would be a situation where the share price was extremely cyclical, and there were both positive signals in the PURCHASE chart and negative plots on the SALE chart. This situation would be highly suggestive of an insider that was timing trades to their financial advantage.

Insider Purchases CC / The Chemours Company - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in CC / The Chemours Company. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
2020-03-13 CC Snell E Bryan 11,000 10.1500 11,000 10.1500 111,650 364 28.7400 204,490 183.15
2019-08-06 CC Snell E Bryan 12,000 13.7700 12,000 13.7700 165,240
2015-11-23 CC Snell E Bryan 15,000 5.9900 15,000 5.9900 89,850
2015-09-14 CC Snell E Bryan 8,000 8.8900 8,000 8.8900 71,120

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

CC / The Chemours Company Insider Trades
Insider Sales CC / The Chemours Company - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in CC / The Chemours Company. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
2020-11-10 CC Snell E Bryan 28,341 22.2900 28,341 22.2900 631,721 2 21.6800 -17,287 -2.74
2017-11-06 CC Snell E Bryan 11,878 53.2500 11,878 53.2500 632,504
2017-09-05 CC Snell E Bryan 13,000 49.3500 13,000 49.3500 641,550
2017-08-11 CC Snell E Bryan 10,000 46.2400 10,000 46.2400 462,400

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

CC / The Chemours Company Insider Trades
Insider Trading History

This table shows the complete list of insider trades made by E Bryan Snell as disclosed to the Securities Exchange Commission (SEC).

File Date Tran Date Form Ticker Security Code 10b5-1 Shares Remaining Shares Percent
Change
Share
Price
Tran
Value
Remaining
Value
2021-03-03 2021-03-01 4 CC Chemours Co
Stock Option (Right to Buy)
A - Award 66,461 66,461
2021-03-03 2021-03-01 4 CC Chemours Co
Common Stock
A - Award 3,748 146,983 2.62
2021-02-17 2021-02-12 4 CC Chemours Co
Common Stock
F - Taxes -807 143,235 -0.56 26.14 -21,095 3,744,163
2021-02-17 2021-02-12 4 CC Chemours Co
Common Stock
A - Award 2,151 144,042 1.52
2020-11-12 2020-11-10 4 CC Chemours Co
Stock Option (Right to Buy)
M - Exercise -28,341 0 -100.00
2020-11-12 2020-11-10 4 CC Chemours Co
Common Stock
S - Sale -28,341 141,891 -16.65 22.29 -631,721 3,162,750
2020-11-12 2020-11-10 4 CC Chemours Co
Common Stock
M - Exercise 28,341 170,232 19.97 15.49 439,002 2,636,894
2020-03-16 2020-03-13 4 CC Chemours Co
Common Stock
P - Purchase 11,000 141,891 8.40 10.15 111,650 1,440,194
2020-03-04 2020-03-02 4 CC Chemours Co
Stock Option (Right to Buy)
A - Award 96,256 96,256
2020-02-19 2020-02-14 4 CC Chemours Co
Common Stock
F - Taxes -6,562 130,891 -4.77 19.37 -127,106 2,535,359
2020-02-19 2020-02-14 4 CC Chemours Co
Common Stock
A - Award 19,679 137,453 16.71
2019-08-06 2019-08-06 4 CC Chemours Co
Common Stock
P - Purchase 12,000 117,774 11.34 13.77 165,240 1,621,748
2019-03-06 2019-03-05 4 CC Chemours Co
Stock Option (Right to Buy)
A - Award 25,087 25,087
2019-02-20 2019-02-15 4 CC Chemours Co
Common Stock
F - Taxes -57,789 103,589 -35.81 37.75 -2,181,535 3,910,485
2019-02-20 2019-02-15 4 CC Chemours Co
Common Stock
A - Award 130,623 161,378 424.72
2018-08-07 2018-08-04 4 CC Chemours Co
Common Stock
F - Taxes -17,890 32,940 -35.20 47.04 -841,546 1,549,498
2018-03-05 2018-03-01 4 CC Chemours Co
Stock Option (Right to Buy)
A - Award 17,518 17,518
2018-02-06 2018-02-04 4 CC Chemours Co
Common Stock
F - Taxes -664 50,548 -1.30 49.22 -32,682 2,487,973
2017-11-08 2017-11-06 4 CC Chemours Co
Stock Option (Right to Buy)
M - Exercise -11,878 0 -100.00
2017-11-08 2017-11-06 4 CC Chemours Co
Common Stock
S - Sale -11,878 51,185 -18.84 53.25 -632,504 2,725,601
2017-11-08 2017-11-06 4 CC Chemours Co
Common Stock
M - Exercise X 11,878 63,063 23.21 11.87 140,992 748,558
2017-09-07 2017-09-05 4 CC Chemours Co
Common Stock
S - Sale -13,000 51,160 -20.26 49.35 -641,550 2,524,746
2017-08-15 2017-08-11 4 CC Chemours Co
Common Stock
S - Sale -10,000 64,160 -13.48 46.24 -462,400 2,966,758
2017-03-10 2017-03-09 4 CC Chemours Co
Common Stock
A - Award 23,746 23,746
2017-02-15 2017-02-13 4 CC Chemours Co
Common Stock
A - Award 40,795 74,091 122.52
2017-02-07 2017-02-05 4 CC Chemours Co
Common Stock
F - Taxes -786 33,295 -2.31 27.62 -21,709 919,608
2017-02-07 2017-02-04 4 CC Chemours Co
Common Stock
F - Taxes -729 34,081 -2.09 27.62 -20,135 941,317
2016-03-03 2016-03-01 4 CC Chemours Co
Stock Option (Right to Buy)
A - Award 110,726 110,726
2016-02-12 2016-02-06 4 CC Chemours Co
Common Stock
F - Taxes -954 34,965 -2.66 4.17 -3,978 145,804
2016-02-12 2016-02-05 4 CC Chemours Co
Common Stock
F - Taxes -746 35,919 -2.03 4.17 -3,111 149,782
2016-02-12 2016-02-04 4 CC Chemours Co
Common Stock
F - Taxes -692 36,665 -1.85 4.40 -3,045 161,326
2015-11-25 2015-11-23 4 CC Chemours Co
Common Stock
P - Purchase 15,000 37,051 68.02 5.99 89,850 221,935
2015-09-16 2015-09-14 4 CC Chemours Co
Common Stock
P - Purchase 8,000 22,051 56.94 8.89 71,120 196,033
2015-07-06 2015-07-01 4 CC Chemours Co
Stock Option (Right to Buy)
A - Award 37,902 37,902
2015-07-06 2015-07-01 4 CC Chemours Co
Stock Option (Right to Buy)
A - Award 28,341 28,341
2015-07-06 2015-07-01 4 CC Chemours Co
Stock Option (Right to Buy)
A - Award 11,878 11,878
2015-07-06 2015-07-01 4 CC Chemours Co
Common Stock, par value $.01
A - Award 13,173 13,253 16,466.25
P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award, or other acquisition of securities from the company (such as an option)
C
Conversion of derivative
D
Sale or transfer of securities back to the company
F
Payment of exercise price or tax liability using portion of securities received from the company
G
Gift of securities by or to the insider
K
Equity swaps and similar hedging transactions
M
Exercise or conversion of derivative security received from the company (such as an option)
V
A transaction voluntarily reported on Form 4
J
Other (accompanied by a footnote describing the transaction)